logo


Array BioPharma to Present at the Baird 2009 Healthcare Conference and the Thomas Weisel Partners 2009 Healthcare Conference
Wednesday, September 02, 2009 12:38 PM


Sep. 2, 2009 (Business Wire) -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Baird 2009 Healthcare Conference on September 9 in New York City and the Thomas Weisel Partners 2009 Healthcare Conference on September 10 in Boston. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website.

 

Event:

Baird 2009 Healthcare Conference

Presenter:

Robert E. Conway, Chief Executive Officer, Array BioPharma

Date:

Wednesday, September 9, 2009

Time:

2:45 p.m. Eastern Time

Location:

Four Season Hotel, NYC

Webcast:

www.arraybiopharma.com

 

Event:

Thomas Weisel Partners 2009 Healthcare Conference

Presenter:

Robert E. Conway, Chief Executive Officer, Array BioPharma

Date:

Thursday, September 10, 2009

Time:

9:45 a.m. Eastern Time

Location:

Four Season Hotel, Boston, MA

Webcast:

www.arraybiopharma.com

 

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

(Source: iStockAnalyst )


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia